Medical and Hospital News
CIVIL NUCLEAR
Framatome and Nuclearelectrica partner to produce Lutetium-177 in Romania
illustration only
Framatome and Nuclearelectrica partner to produce Lutetium-177 in Romania
by Erica Marchand
Paris, France (SPX) Nov 13, 2024

Framatome and SN Nuclearelectrica SA (BVB:SNN) have announced a long-term agreement to collaborate on the production of the medical isotope Lutetium-177 (Lu-177) at Romania's Cernavoda nuclear power plant. This isotope is pivotal in modern cancer treatment protocols.

The agreement was formalized during a special event hosted by the French Ambassador in Bucharest, Nicolas Warnery, and attended by key Romanian officials, including Alexandru-Mihai Ghigiu, Head of the Prime Minister's Chancellery, and Dr. Tiberius Marius Bradaan, State Secretary at the Ministry of Health.

"Nuclearelectrica's involvement in this large-scale project brings Romania into the elite of the global nuclear industry, concerned not only with clean energy production, but also with innovative health solutions. The Government led by Prime Minister Marcel Ciolacu strongly supports this project, as well as all initiatives that improve people's quality of life, including through the discovery and introduction of state-of-the-art medical treatments," said Alexandru-Mihai Ghigiu.

Highlighting the impact on public health, Romania's Minister of Health, Prof. Alexandru Rafila, stated, "The production of the Lutetium-177 isotope is a key achievement for public health, as this radioisotope enables modern therapies that directly target cancer cells, thus offering a precise and minimally invasive treatment. This project reflects Romania's commitment to support research and innovation in the field of applied medical technologies, strengthening our ability to respond to national and regional needs for radioisotopes. At a time of increasing global demand for such resources, it is essential that Romania contributes to the development and diversification of these vital solutions for patients."

The French Ambassador to Romania, Nicolas Warnery, emphasized the significance of the partnership, noting, "This collaboration on Lutetium-177 marks a significant achievement, reflecting our two countries' commitment to working together to foster European self-sufficiency in radioisotopes. It also highlights a frequently underestimated positive aspect of nuclear energy: its potential for innovation and its critical role in nuclear medicine."

The technology for producing Lu-177 will be provided by Framatome, marking a substantial development in enhancing nuclear medicine in Romania. "Nuclear technologies play a crucial role in modern healthcare. They are essential in the fight against cancer and Framatome has a long-standing presence in the field of healthcare," said Bernard Fontana, CEO of Framatome. "We are proud to bring our innovative isotope production technology and join forces with SNN to strengthen the supply chain for lifesaving radioisotopes in Europe."

The collaboration follows a successful feasibility study earlier this year, which confirmed the compatibility of Framatome's technology to irradiate Ytterbium-176 at Unit 2 of Cernavoda to produce Lutetium-177. The engineering and industrialization phase is now underway, with production aimed to commence by 2028.

Cosmin Ghia, CEO of Nuclearelectrica, stated, "This partnership with Framatome for the production of Lutetium-177 demonstrates our dedication to supporting innovation in nuclear medicine and contributing to advanced cancer treatments. Through this initiative, Romania is aligning with international efforts to develop more effective medical solutions for patients around the world."

Lu-177 is essential in targeted radionuclide therapy for prostate cancer and other potential cancer treatments, selectively eliminating cancer cells while sparing healthy tissue. Framatome pioneered large-scale commercial production of this isotope in a power reactor in June 2022.

Related Links
Framatome
Nuclear Power News - Nuclear Science, Nuclear Technology
Powering The World in the 21st Century at Energy-Daily.com

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
CIVIL NUCLEAR
Climate cash should also go to nuclear, says UN atomic chief
Baku (AFP) Nov 12, 2024
The head of the United Nations nuclear watchdog said Tuesday that atomic power should also be allowed to tap into climate change funds. International Atomic Energy Agency (IAEA) chief Rafael Grossi said he wanted countries from Kenya to Malaysia to go for nuclear, while denying he was pushing for an "irresponsible race" towards civil atomic power. Should nuclear get climate financing? "It should. Already at COP28 in Dubai the international community - not just nuclear countries - agreed th ... read more

CIVIL NUCLEAR
Keeping global consumption within planetary boundaries

China snuffs out memorials to victims of deadly car ramming attack

Climate crisis worsening already 'hellish' refugee situation: UN

Spain PM accused of 'blackmail' by tying budget to flood aid; Royals return to flood zone

CIVIL NUCLEAR
N. Korea jams GPS signals, affecting ships, aircraft in South

Successful demo showcases BAE Systems' next-gen M-Code GNSS technology

BeiDou remote sensing experiment enhances ecological monitoring in Yellow River

Aerodata earns EASA certification for GPS anti-jamming and anti-spoofing tech

CIVIL NUCLEAR
Chimpanzees show improved performance on difficult computer tasks with an audience

New findings on Denisovans reveal their role in shaping early human genetics

Memories extend beyond the brain in new NYU study

Human culture's distinctiveness lies in its open-ended nature

CIVIL NUCLEAR
New tools give researchers hope for fungus-ravaged US bats

Critically endangered Sumatran elephant calf born in Indonesia

Young Again: Study Shows Comb Jellies Can Reverse Aging

Summit to save nature enters final day with disagreement on funding

CIVIL NUCLEAR
Spread of dengue fever in Bangladesh worries medics

Climate shifts and urbanisation drive Nepal dengue surge

Covid lessons learned? UN summit mulls plan for healthy planet, and humans

WHO launches plan to rein in 'alarming' dengue spread

CIVIL NUCLEAR
Chinese slimmers trim down at weight-loss camps

China's Myanmar consulate hit with explosive device: Junta chief to visit China next month

China to almost double support for unfinished housing projects

Myanmar junta chief to travel to China next month: sources close to military

CIVIL NUCLEAR
El Salvador troops target gangs in large-scale operation

Hungary's Orban says corks will pop if Trump wins US election

CIVIL NUCLEAR
Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.